- Home
- EQR vs STE Comparison
EQR vs STE Comparison
Compare EQR & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EQR | STE |
|---|---|---|
| Founded | 1993 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Industrial Specialties |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.5B | 25.9B |
| IPO Year | 1993 | 1992 |
Fundamental Metrics
Financial Performance| Metric | EQR | STE |
|---|---|---|
| Price | $61.50 | $263.47 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 9 |
| Target Price | $70.00 | ★ $268.25 |
| AVG Volume (30 Days) | ★ 2.1M | 674.3K |
| Earning Date | 10-28-2025 | 11-05-2025 |
| Dividend Yield | ★ 4.54% | 0.96% |
| EPS Growth | 24.49 | ★ 59.39 |
| EPS | 3.03 | ★ 6.97 |
| Revenue | $3,078,827,000.00 | ★ $5,702,415,000.00 |
| Revenue This Year | $5.06 | $9.24 |
| Revenue Next Year | $3.55 | $6.30 |
| P/E Ratio | ★ $20.13 | $37.72 |
| Revenue Growth | 4.69 | ★ 7.08 |
| 52 Week Low | $58.38 | $200.98 |
| 52 Week High | $75.86 | $268.60 |
Technical Indicators
Market Signals| Indicator | EQR | STE |
|---|---|---|
| Relative Strength Index (RSI) | 50.24 | 59.06 |
| Support Level | $61.02 | $256.68 |
| Resistance Level | $62.42 | $268.60 |
| Average True Range (ATR) | 0.90 | 4.64 |
| MACD | 0.26 | -0.69 |
| Stochastic Oscillator | 62.17 | 65.59 |
Price Performance
Historical ComparisonAbout EQR Equity Residential of Beneficial Interest
Equity Residential owns a portfolio of 312 apartment communities with over 84,000 units and is developing two additional properties with 655 units. The company focuses on owning large, high-quality properties in the urban and suburban submarkets of Southern California, San Francisco, Washington, D.C., New York, Seattle, and Boston.
About STE STERIS plc (Ireland)
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.